Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women.
OBJECTIVE
This study was carried out to assess the effect of topical androgen replacement therapy on body weight, body composition and fat distribution in postmenopausal women.


METHODS
39 healthy postmenopausal women (51.4 +/- 2.24 years), with increasing body weight, were prospectively studied for 6 months. Body composition (fat mass, kg, %) was measured by means of dual-energy X-ray absorptiometry (DXA). Hormonal and lipid parameters were also measured. Subjects were divided into two groups. An androgen gel (group A) or placebo gel (group P) was topically administered to the abdominal and gluteo-femoral regions. DXA was performed before commencement of topical treatment and after 6 months.


RESULTS
A highly significant total body weight reduction was found in group A (68.0 +/- 13.1 to 65.4 +/- 11.8 kg). Abdominal fat (37.3 +/- 11.2 to 35.1 +/- 9.7%), gluteo-femoral fat (46.3 +/- 6.6 to 45.4 +/- 7.7%), total body fat (38.2 +/- 7.9 to 36.1 +/- 8.6%) and BMI (24.8 +/- 4.3 to 23.7 +/- 3.8) were also found to have decreased significantly in this group. No significant reduction in body weight (kg) and body fat (%) could be measured in the placebo group. No influence on lipid parameters was found although total testosterone increased significantly in group A (0.29 +/- 0.24 to 0.72 +/- 0.17 ng/ml).


CONCLUSIONS
Topically applied androgen is capable of reducing abdominal fat accumulations as well as total body weight in postmenopausal women with unexplained weight gain. In contrast to systemic androgen application, topical administration has no effect on the lipid profile. Gluteal fat, however, is less effectively influenced by androgens.
Department of Gynecological Endocrinology and Reproductive Medicine, University of Vienna, Wien, Austria. Doris.Gruber@akh-wien.ac.at
D M
DM
Gruber
M O
MO
Sator
S
S
Kirchengast
E A
EA
Joura
J C
JC
Huber
D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D013196:Dihydrotestosterone / Q000008:administration & dosage*; D004338:Drug Combinations; D005260:Female; D005782:Gels; D012739:Gonadal Steroid Hormones / Q000097:blood; D020249:Hormone Replacement Therapy; D006801:Humans; D008875:Middle Aged
D004338:Drug Combinations; D005782:Gels; D012739:Gonadal Steroid Hormones; D013196:Dihydrotestosterone